eduKate Singapore

VIEW THIS AS

Auto mode follows the Route Engine until you choose a viewpoint.

YOU ARE HERE

ROUTE CHECK

CONNECTED TO

WHAT NEXT

Use the canonical route for this room, or HELP if you are unsure.

Next useful routeCanonical hubHELP

Why Study Science | Understand Vaccines and Immune Memory

—

by

eduKate Asia
People waiting in separated seating at a COVID-19 vaccination centre in Singapore.

Why study Science? Vaccines show how the immune system can recognise specific antigens and develop memory. Understanding their Biology also teaches students how to evaluate claims about protection, clinical evidence, safety and uncertainty without expecting any intervention to be perfect.

Short answer: vaccination can prepare immune defences against specified infectious diseases. B cells, T cells, antibodies and memory responses all contribute to protection, while vaccine trials and public-health surveillance examine what those mechanisms mean in practice.

This Singapore-facing article is an educational explanation, not personal vaccination advice. All numerical trial data used below are fictional. Official WHO, HealthHub, MOH and HSA links are provided, with dated 2026 policy changes identified for clarity.

Contents

Vaccines make the invisible immune system easier to understand

A child may receive a routine immunisation, hear that more than one dose is recommended or wonder why a vaccine can help protect against disease without guaranteeing that an infection will never occur. Those questions are a valuable entry into Biology because they require the student to distinguish the germ, the immune response and the outcome being measured.

Vaccines are a practical reason to study Science. They reveal how cells recognise molecular features, how immune memory can develop and why protection is evaluated with evidence gathered across many people rather than by judging one individual’s experience.

Scientific understanding also matters when schedules or recommendations change. A new policy date, a different vaccine formulation or an updated eligibility category is a public-health decision based on evidence and practical context. It does not change the underlying meaning of an antigen or an antibody.

This article explains the biology and the reasoning behind evaluating claims. It does not choose vaccines for a particular person, replace Singapore Ministry of Health guidance or interpret an individual’s medical history.

What is a pathogen?

A pathogen is an organism or infectious agent capable of causing disease under relevant conditions. Bacteria and viruses are familiar examples, but they differ in structure and replication. Some pathogens produce toxins, damage tissues directly or stimulate harmful inflammatory responses.

An important distinction is that not every bacterium is a pathogen. Many microorganisms are harmless or beneficial in particular contexts. A vaccine is generally designed to help protect against a specified infectious disease or its consequences, not to eliminate all microbes from the body.

A strong Science answer identifies the relevant agent and disease instead of using the word germ as an explanation for every symptom.

That precision becomes essential when comparing a viral infection, a bacterial illness and the effects of a bacterial toxin. Their prevention and treatment mechanisms are not interchangeable.

An antigen is something the immune system can recognise

An antigen is a molecular structure or substance recognised by components of the adaptive immune system. It may be a protein or another suitable molecular feature associated with a pathogen, or part of a vaccine designed to induce a response.

Different vaccines present antigens through different technologies. Some deliver a selected protein; some use an inactivated or weakened organism under appropriate conditions; others deliver instructions that allow cells to produce an antigen for immune recognition.

Students should not assume the word antigen means an active infectious organism. The antigen is the target or stimulus for recognition, and its presentation can occur without the disease process that an uncontrolled infection might cause.

Science helps by separating the biological information shown to the immune system from the many ways a pathogen causes illness.

The immune system has more than one layer

The body’s defences include physical barriers, innate responses and adaptive immune mechanisms. Skin and mucosal surfaces help limit entry. Innate immune cells and signalling respond rapidly to many kinds of disturbance.

Adaptive immune responses can target specific antigens and develop memory. B cells and T cells contribute different functions, and these processes interact with innate responses rather than operating as isolated departments.

The simple classroom picture of one antibody defeating one virus may be useful at first, but it leaves out a network of recognition, signalling, cell movement and regulation.

A learner should see these mechanisms as coordinated parts of a living system. Immunity is neither a single substance nor an on/off switch.

Antibodies bind recognised targets

Antibodies are proteins produced by plasma cells derived from B cells. They can bind particular antigenic features. Depending on the target and circumstances, antibodies may help neutralise a pathogen or toxin and promote other immune processes.

The familiar Y-shaped antibody drawing is a model that helps show binding sites, but real antibodies vary in structure and class. Binding is not always equivalent to complete protection from infection.

A laboratory may measure antibody concentrations or functions, yet such results cannot be interpreted as a universal measure of individual immunity for all diseases. Protective responses can also involve T cells and other mechanisms.

The value of studying Science is the ability to distinguish one measurable component from the entire biological outcome.

B cells and immune memory

Some activated B cells become antibody-producing plasma cells, while others develop into memory B cells. These memory cells may help the immune system respond more rapidly or effectively on later encounters with relevant antigens.

Antibody concentrations in blood can decline over time even when memory B cells persist. The relationship between measured antibodies and clinical protection differs across pathogens, vaccines and individuals.

That is why immune memory should not be described as one permanent bottle of antibodies sitting in the body. It is a biological capacity associated with populations of cells and their subsequent responses.

Science students can use this example to distinguish a measurement taken now from a system’s ability to change after a future challenge.

T cells contribute different kinds of defence

T cells include populations involved in coordinating immune responses and detecting or responding to infected cells. Some develop memory characteristics after an immune encounter.

Antibodies and T-cell responses therefore offer different kinds of information. For a particular vaccine, protection may involve several immune mechanisms rather than only the amount of antibody a laboratory can measure.

A child who knows the names B cell and T cell should still ask what each cell population does and what evidence supports a claim about it.

This turns vocabulary into mechanism-based reasoning and helps explain why immune protection cannot always be reduced to a single test result.

A primary immune response takes time

When the immune system encounters a new antigen, relevant cells must be activated, multiply and develop appropriate functions. That process takes time, so protection does not appear instantaneously after every vaccination.

The World Health Organization notes that doses may be spaced to allow an immune response and the development of longer-lasting protection. The time needed varies by vaccine, dose history and individual circumstances.

A student should not infer that a person is fully protected in the minute after receiving an injection, nor that a delayed response means the vaccine has no value.

Science teaches that biological processes have timescales, just as plant growth, chemical reactions and development do.

A secondary response can be faster

On a later encounter with a relevant antigen, memory cells can contribute to a quicker or stronger adaptive response. This is one of the central ideas behind vaccination and immune memory.

But ‘faster’ is not a promise that every infection is blocked at the point of entry. Pathogens can replicate before a response clears them, variants may differ from previously recognised antigens and immunity can vary across individuals.

Different outcomes must therefore be examined separately: infection, symptomatic disease, severe disease, hospitalisation and death are not the same endpoint.

Learning this distinction helps pupils understand why scientific descriptions of protection need to specify which consequence was studied.

Vaccines provide a controlled way of presenting antigens

A vaccine is developed to stimulate protective immunity against a specified disease while avoiding the risks associated with acquiring that disease through uncontrolled infection. Vaccine technologies vary, and each is evaluated for particular uses.

For example, protein-based vaccines supply an antigenic component, while certain mRNA vaccines provide temporary genetic instructions that cells can use to make an antigen. Inactivated and live-attenuated vaccines use different approaches with different suitability considerations.

The unifying principle is immune recognition, not one universal ingredient list. A learner should avoid claiming every vaccine contains live virus or every vaccine works by altering human DNA.

Science becomes more accurate when students understand shared goals while keeping the mechanisms of different technologies distinct.

A weakened live vaccine is not the same as an inactivated vaccine

Live-attenuated vaccines contain an appropriately weakened form of a pathogen capable of producing an immune response under controlled use. Inactivated vaccines use material that has been rendered unable to reproduce as an infectious agent in the way the original pathogen does.

Because these technologies differ, considerations including dose schedules and suitability for some medical conditions can differ too. The responsible comparison refers to a specific approved product and official guidance.

Students should not treat all vaccine types as identical or assume that an educational explanation provides enough information to decide whether a live vaccine is appropriate for one individual.

This is a good example of using classification to understand differences instead of merely compiling names.

How mRNA vaccines work

Messenger RNA provides instructions that cells can translate into a protein. Certain mRNA vaccines deliver laboratory-produced mRNA coding for a selected pathogen antigen. The recipient’s cells use that information to make the antigen, which can stimulate an immune response.

Singapore’s Ministry of Health explains this mechanism for mRNA COVID-19 vaccines: the vaccine’s mRNA is used to produce an antigenic protein, while the mRNA is subsequently broken down. It does not need to become part of the person’s nuclear genome to operate.

The distinction between temporary expression of an antigen and changing inherited DNA matters. Confusing the two involves mixing separate biological processes that pupils can learn to recognise.

An educational account of mRNA explains the concept; it does not predict a specific person’s reactions or select a vaccine product.

An immune memory response is not permanent perfection

Some vaccines induce protection that persists for many years, while protection against other diseases may wane or be affected by changes in the circulating pathogen. There is no universal duration that can be assigned to every vaccine.

Booster doses can sometimes strengthen or update responses according to the evidence and national recommendations. Some vaccination series need multiple doses from the outset; others require different intervals or do not use the same booster approach.

A student should avoid interpreting the word memory as a promise that no new infection can ever occur. Biological memory is dynamic and disease-specific.

The scientifically correct question is what kind of protection was measured, for which pathogen, in which population and over what interval.

Why a vaccine schedule may involve several doses

A vaccine schedule is designed using evidence about age, immune development, disease risk, response after each dose and the duration of protection. A primary series and subsequent booster doses can serve different purposes.

Students should not infer that a vaccine ‘failed’ because a programme recommends a later dose. Multiple exposures can be part of the intended mechanism for generating and maintaining protection.

Similarly, a missed or delayed dose does not have one universal correction for every product. Catch-up recommendations depend on the specific vaccination history and official guidance.

Families should use HealthHub or their healthcare provider for the current Singapore schedule rather than extrapolating from a classroom diagram.

Singapore’s childhood immunisation schedule has defined public rules

Singapore’s National Childhood Immunisation Schedule lists nationally recommended vaccinations and is reviewed by the Ministry of Health with expert advice. The Health Promotion Board also provides school-based vaccination services for specified programmes.

As of 23 October 2026, MOH has announced that COVID-19 vaccination joined the national childhood and adult schedules from 12 October 2026. A separate MOH announcement states that nine-valent HPV vaccination will be added to the schedules for eligible females from 1 January 2027.

These are dated policy details, not biological definitions. The source and effective date matter because official schedules may change after a new decision.

The educational lesson is to distinguish a stable mechanism of immunity from a time-sensitive public-health recommendation.

Why public guidance must be dated

A screenshot of a vaccine schedule from an earlier year may still show real historical information but omit newer recommendations or eligibility changes. Its age matters when a parent is making a practical appointment.

A Science student should learn to locate the issuing body, update date, target group, product and effective date. The same questions apply to laboratory protocols, disease notices and medication instructions.

That habit does not require the student to make medical decisions. It requires them to recognise when a document’s authority and currency determine whether it is appropriate to use.

Scientific literacy includes following the evidence and the institutional process through which public recommendations are maintained.

Safety testing and monitoring answer different questions

Before authorisation, vaccines undergo research and evaluation for safety, immunogenicity and effectiveness according to the product and regulatory process. After introduction, safety surveillance can detect, investigate and assess possible adverse reactions in broader populations.

A clinical trial can be carefully controlled while still having limits on its sample size and the frequency of rare events. Post-authorisation monitoring helps assess experience across many people and changing circumstances.

Singapore’s Health Sciences Authority receives and evaluates adverse-event reports as part of its regulatory responsibilities. A report is a signal for investigation, not automatic proof that the vaccine caused the reported event.

Science teaches why continued measurement is a strength of a safety system rather than a contradiction of earlier testing.

An event after vaccination is not automatically caused by vaccination

Suppose someone develops a symptom two days after receiving a vaccine. The sequence of events establishes timing, but causation requires further evidence. Symptoms also occur in unvaccinated populations for many reasons.

Regulators look for clinical patterns, timing, background rates, biological plausibility and other evidence. Some adverse reactions are recognised; other reported events may be coincidental or remain uncertain.

HSA’s guidance on adverse events following immunisation explicitly recognises that an event can be reported even when a causal link has not been established.

This is one of the most transferable lessons of Science: ‘after’ is a chronological description, not by itself a causal explanation.

Common and rare adverse effects need separate discussion

Vaccines can have adverse effects, including temporary discomfort, soreness or fever for some products and recipients. Serious adverse reactions can also occur but are generally much less common and must be evaluated through appropriate evidence.

A scientifically responsible description names the vaccine and the adverse effect rather than treating every reaction as equally likely or severe. It also distinguishes the documented risks of vaccination from the risks of the disease the vaccine is designed to prevent.

An educational article cannot assess whether a particular new symptom is caused by a vaccine or whether an individual should receive another dose. Healthcare professionals and official guidance are needed for that purpose.

Understanding the distinction between frequency, severity and causation improves the quality of public-health discussion.

Risk comparison needs a defined outcome and population

A sentence such as ‘vaccination is safer’ is more informative when it states what is being compared: a particular adverse outcome following a particular vaccine versus the probability and severity of the same or other outcomes from infection in a defined population.

Risk varies by age, health and epidemiological conditions, so it is not always meaningful to transfer one published percentage to every person and period. Good comparisons use compatible denominators, measurement methods and time windows.

Students should resist the temptation to set two unrelated headline percentages side by side without checking whether they refer to the same endpoint.

That numerical discipline is a major benefit of Science education because it applies to medication, engineering safety and everyday decision-making as well as vaccines.

Vaccine efficacy and vaccine effectiveness are different terms

Efficacy typically describes the reduction in a specified outcome measured under the conditions of a controlled clinical trial. Effectiveness describes performance in real-world conditions as assessed through suitable observational or other studies.

Neither figure is one universal property of a vaccine regardless of disease variant, dose timing or outcome. Protection against symptomatic disease can differ from protection against severe disease, and results can change over time.

Students should read the endpoint and study design before repeating a percentage. A figure of 90 per cent does not mean 90 of every 100 vaccinated people are permanently protected from all possible outcomes.

Science helps people understand what a trial actually tested rather than what a headline suggests.

Worked example: interpreting relative risk reduction

Invented classroom trial, not a published vaccine result: suppose two equally sized groups of 1,000 people are followed for the same defined period. In the unvaccinated comparison group, 100 experience a specified outcome; in the vaccinated group, 30 do.

The observed risks are 100 ÷ 1,000 = 10 per cent and 30 ÷ 1,000 = 3 per cent. The relative risk reduction is (10 − 3) ÷ 10 = 70 per cent. The absolute risk reduction is 7 percentage points.

These are different numerical descriptions of the same fictional result. The 70 per cent figure is not the proportion of people who acquired immunity, and it cannot be assumed to apply to unrelated outcomes.

Real vaccine studies also require confidence intervals, careful outcome definitions, randomisation or other bias controls and suitable follow-up. This simple arithmetic is a teaching exercise, not a medical prediction.

  • Comparison-group risk: 10%.
  • Vaccinated-group risk: 3%.
  • Absolute risk reduction: 7 percentage points.
  • Relative risk reduction: 70%.
  • These numbers are fictional and endpoint-specific.

Why the denominator changes the story

Imagine a report of five cases following vaccination but no statement of how many doses were given or how many people were followed. The raw count does not show the event’s frequency.

Five events among 500 people represents a different proportion from five events among five million. Moreover, calculating a rate does not establish that the events were caused by the vaccination.

Students should identify population size, follow-up period and outcome definition before interpreting a risk statement. Comparisons also need context about the underlying rate among people who were not exposed.

The habit of asking ‘five out of how many, over how long?’ is an essential Science and numeracy skill.

Why confidence intervals appear in medical research

A study samples a population and is affected by random variation. A confidence interval summarises uncertainty around an estimated measure under an adopted statistical method.

Two reported percentages may appear different while the available evidence is insufficient to establish a meaningful difference, particularly when the number of events is small. Conversely, a large sample may estimate a modest effect more precisely.

Students need not calculate advanced confidence intervals immediately, but they should understand why one exact-looking percentage is not a guarantee about every future population.

This lesson connects Science with statistical reasoning and encourages careful reporting of what a study can establish.

Why a positive infection test does not automatically prove vaccine failure

No vaccine prevents every possible infection or disease outcome. Immune responses take time and vary; pathogen exposure may differ; and protection against one endpoint may not be identical to protection against another.

A post-vaccination infection can therefore occur even when a vaccine substantially reduces risk at population level. The relevant evaluation compares rates and severity under appropriately controlled conditions.

A single case is important for that individual but does not by itself measure overall vaccine performance. Population evidence and individual clinical assessment answer different questions.

Scientific literacy requires us to avoid both extremes: claiming a vaccine is perfect and declaring a vaccine useless whenever a breakthrough infection is reported.

Immune response and protection are not always the same measurement

Laboratories can measure certain antibody levels or other immune responses following vaccination. Such results help researchers investigate how a product works and may sometimes correlate with protection.

However, a higher antibody number does not always translate directly into an equal proportional increase in clinical protection across individuals and diseases. The relevant relationship must be established empirically.

A statement such as ‘this product produces twice as many antibodies’ requires context about the assay, target and sampling time before it can justify a clinical claim.

Science teaches that a proxy measurement can be useful without being identical to the outcome the public cares about.

Why variants matter without making immune memory meaningless

Viruses and bacteria can vary genetically, and some changes affect antigenic structures recognised by immune responses. This can alter the degree to which previous vaccination or infection protects against certain outcomes.

That does not mean all immune memory disappears whenever a new variant circulates. Responses can recognise multiple antigenic features and may retain protection against important outcomes even when infection-blocking performance changes.

Evaluating variant effects requires laboratory measurements, epidemiological observations and clinical data. A single mutation announcement is not enough to determine the entire level of protection.

Science helps students understand evolution and immune recognition together without falling into all-or-nothing claims.

Why the population context matters

Protection against infection can sometimes reduce opportunities for onward transmission and help shield other people, particularly when vaccination is widespread and pathogen properties permit such effects.

The magnitude of indirect protection depends on factors including transmissibility, vaccine performance against infection, contact patterns, coverage and how long relevant protection persists. It is not identical for every disease.

Community or herd immunity should therefore be taught as a population phenomenon rather than a magical threshold that guarantees safety for every individual.

The educational purpose is to understand how individual biological effects can influence the spread of a pathogen across a network of contacts.

A simplified transmission chain is not a forecast

Imagine a fictional classroom diagram showing one infected person and three potential contacts. It may illustrate how reducing the probability of infection on each contact could interrupt some transmission paths.

But the outcome also depends on the timing of contacts, susceptibility, behaviour, ventilation, duration and characteristics of the pathogen. Counting three arrows is not an epidemiological model.

Students can learn why public-health decisions use several kinds of evidence while still keeping school examples modest and clearly hypothetical.

Science is most trustworthy when it shows what a simplified mechanism explains and what would require a more detailed model.

Antibiotics and vaccines are not interchangeable

Antibiotics act against susceptible bacteria through pharmacological mechanisms. Vaccines aim to develop an immune response against specified infectious diseases before exposure or illness. The two approaches may sometimes both be relevant in disease control, but they work differently.

Antibiotics do not treat ordinary viral infections, and vaccination does not function as a universal immediate cure for an established infection. Clinical treatment and preventive vaccination require professional decision-making.

Students should identify the pathogen category, the intervention’s timing and its mechanism before drawing conclusions.

This distinction is another useful reason to study Biology: similar goals of protecting health can require very different scientific methods.

Vaccination does not replace other prevention measures in every setting

Different infectious diseases spread through different routes. Ventilation, hygiene, sanitation, vector control, safe food handling and appropriate clinical care can complement vaccination depending on the pathogen.

An immunisation schedule is not a substitute for clean water, and washing hands does not replace a vaccine where vaccination is recommended. They address different parts of a disease-prevention system.

Students can draw a pathway showing source, transmission, exposure and host response and then place each preventive measure where it operates.

Science helps learners avoid searching for one universal solution to a problem that has several interacting stages.

Singapore’s vaccination records support continuity of care

HealthHub provides ways for eligible users to review immunisation information in Singapore’s health ecosystem. Records matter because vaccination history, intervals and prior doses can influence the next appropriate clinical step.

A school Science article is not the right place to request or display a student’s personal vaccination records. Families should access relevant information through authorised accounts and healthcare providers.

Learning about record-keeping helps students connect science with data accuracy, continuity and privacy rather than viewing the schedule as only a poster of disease names.

The general lesson is that biological interventions happen over time, and reliable records prevent decisions from being based on guesswork.

How to investigate vaccine claims responsibly

Start by identifying the disease and outcome. Ask whether a claim concerns preventing infection, reducing severe illness, building an antibody response or reporting an adverse event. These are different scientific statements.

Next examine the population, timing, vaccine product and study design. A laboratory experiment, randomised trial, observational study and adverse-event report each supply different evidence and have different limitations.

Finally check current primary sources, including WHO, Singapore MOH, HPB or HSA as relevant. Be cautious when a chart lacks axes, dates or denominators.

This procedure protects understanding without asking students to adjudicate individual medical questions or replace healthcare advice.

What a school learning task should never demand

A Biology lesson should not require pupils to disclose their personal vaccination status, provide health records, undergo testing or reveal a family member’s medical history. The mechanisms can be learned from fictional datasets and publicly available diagrams.

Likewise, an educational article should not create pressure to make a clinical decision based on a simplified trial example. Consent, eligibility and individual healthcare considerations belong in appropriate professional settings.

Science education succeeds when it builds informed reasoning while respecting personal privacy and the limits of classroom expertise.

Common misconceptions about vaccines

One misconception says every vaccine contains a live pathogen; another claims vaccination makes infection impossible. Some students believe that an adverse event occurring after vaccination automatically proves causation, or that boosters demonstrate the earlier doses were pointless.

More subtle errors confuse antibodies with the entire immune system, mix relative risk reduction with the proportion of people protected, or interpret an mRNA vaccine as changing inherited DNA.

Correct each claim by naming the mechanism, the appropriate endpoint and what evidence is needed. The aim is conceptual clarity rather than repeating slogans in favour of one side of a debate.

Students become more scientifically literate when they can distinguish a supported concern, a documented effect and an unsupported inference.

  • A vaccine may present an antigen in several different ways.
  • Immune memory does not guarantee perfect, lifelong protection.
  • Antibodies are one component of adaptive immunity.
  • Relative and absolute risk reductions are different.
  • Temporal association alone does not establish an adverse event’s cause.
  • A booster may be part of the intended schedule.
  • An mRNA vaccine does not require changing nuclear DNA.
  • Official recommendations are time-sensitive and population-specific.

A two-week Biology learning plan

Begin with the structure of pathogens, antigens and the roles of innate and adaptive immunity. Ask the pupil to draw a short sequence: antigen recognition, activation of relevant cells, response and formation of memory under appropriate conditions.

Next compare several vaccine technologies conceptually without dosing details or individual recommendations. Introduce the difference between prevention of infection and prevention of severe disease, and discuss why study endpoints matter.

During week two, calculate relative and absolute risk reductions using the invented 1,000-person example. Then examine the dated official Singapore HealthHub immunisation page and identify which statements are stable biological principles and which are schedule updates.

Finish with an unfamiliar claim and a source-checking exercise. Students should be able to explain which quantity or evidence is missing while leaving medical decisions to qualified professionals.

  • Days 1–3: pathogen, antigen and immune response.
  • Days 4–5: B cells, T cells and memory.
  • Days 6–7: different vaccine technologies and timing.
  • Days 8–9: efficacy, effectiveness and endpoints.
  • Days 10–11: risk-reduction arithmetic and denominators.
  • Days 12–13: Singapore schedules and safety monitoring.
  • Day 14: independently audit a scientific claim.

How parents can discuss the Science constructively

Ask what an antigen is and how immune memory can help later. If a child says a vaccine must block every infection to have value, ask which disease outcome a clinical study was designed to measure.

If they repeat a statistic, ask who was studied, over what period and what the denominator was. If they encounter conflicting dates, check the official update rather than assuming both documents refer to the same policy.

Parents need not disclose private health information or debate another person’s medical choices to teach these concepts. A neutral fictional example can demonstrate rigorous reasoning.

The strongest outcome is a learner who asks better scientific questions without becoming overconfident about medical issues.

What this article cannot decide

It cannot recommend a particular vaccination or dose for any individual, evaluate symptoms, determine the cause of an adverse event or replace Singapore’s current official schedule and healthcare guidance.

Those questions require personal medical context, authorised products, current policy and qualified clinical judgement. An accurate explanation of immune cells is not a clinical eligibility assessment.

The educational purpose is to understand why immune memory matters and how trustworthy evidence supports public-health conclusions.

The lasting reason to study Science

Vaccines demonstrate how molecular recognition and memory within living cells can influence outcomes across populations. The chain runs from antigens and immune responses to careful clinical trials, surveillance and public recommendations.

Students who understand this chain can distinguish a mechanism from a claim of certainty and a study statistic from an individual’s prognosis.

That is why Science is worth studying: it gives people the tools to understand how evidence is built and to respect the limits of what one number, story or experiment can show.

Frequently asked questions

What is an antigen?

A molecular structure or substance recognised by components of the adaptive immune system.

How can vaccines produce protection?

They stimulate a relevant immune response to selected antigens, helping develop defences and immune memory against specified diseases.

What are antibodies?

Proteins made by plasma cells derived from B cells that recognise and bind particular antigens.

What is immune memory?

The capacity of specialised immune cells and responses to act more rapidly or effectively after a relevant later encounter.

Do all vaccines contain a live virus?

No. Technologies include inactivated, protein-based, live-attenuated and nucleic-acid approaches, among others.

Can vaccinated people still get infected?

Yes. Protection is not always complete and varies by disease, vaccine, time and outcome.

Why are booster doses sometimes given?

They can strengthen or maintain appropriate immunity according to the evidence and the specific vaccine schedule.

Does mRNA vaccination change someone’s DNA?

The standard mRNA vaccine mechanism uses temporary instructions for producing an antigen; it does not require integration into nuclear DNA.

What is vaccine efficacy?

A measure of reduction in a specified outcome under controlled study conditions, commonly expressed as relative risk reduction.

Is efficacy the same as real-world effectiveness?

Not exactly. Effectiveness assesses performance under real-world conditions and can depend on population, timing and context.

Can an adverse-event report prove a vaccine caused a symptom?

Not by itself. Reports are evaluated for causality using clinical and epidemiological evidence.

Can vaccination be useful even if infection occurs?

Yes. Protection against severe disease can differ from protection against any infection and should be evaluated separately.

Where can Singapore parents find the latest schedule?

Use current HealthHub and Ministry of Health resources or consult a healthcare provider.

Was COVID-19 vaccination incorporated into Singapore’s national schedules in 2026?

MOH announced incorporation from 12 October 2026; consult its official updates for current eligibility and recommendations.

Will Singapore’s HPV9 schedule change in 2027?

MOH announced an HPV9 addition for eligible females beginning 1 January 2027. Check official guidance for current policy.

Should students share personal vaccination records in class?

No. Fictional examples can teach the Science without disclosing private health information.

Official sources and further learning

WHO and CDC explain vaccine mechanisms and immune memory. Singapore MOH, HealthHub and HSA provide the local schedule, dated policy decisions and safety-surveillance context. The fictitious trial calculations illustrate relative and absolute risk reduction and are not actual efficacy estimates.

The eduKateSG approach is to teach the mechanism carefully, define the evidence, examine a changed scenario and leave clinical decisions to appropriate professionals.